论文部分内容阅读
目的:总结支气管袖状肺叶切除术治疗52例中心型肺癌的临床经验。方法:回顾性分析本院在1987年1月~2008年5月期间收治的中心型肺癌52例,其中Ⅰb期17例(T2N0M0),Ⅱb期29例(T2N1M0,T3N0M0),Ⅲa期6例(T2N2M0);支气管袖状肺叶切除43例,肺动脉和支气管双袖状肺叶切除9例。结果:手术死亡率1.9%(1/52)。术后并发肺不张3.8%(2/52),脓胸1.9%(1/52)。术后随访1~48个月,1年生存率为80.21%,3年生存率38.23%。结论:以支气管或肺动脉袖状切除能提高中心型肺癌的手术切除率,并可最大限度保护肺功能,保证病人术后生活质量。
Objective: To summarize the clinical experience of bronchial sleeve lobectomy for the treatment of 52 patients with central lung cancer. Methods: A total of 52 patients with central lung cancer admitted to our hospital from January 1987 to May 2008 were retrospectively analyzed. Among them, 17 cases were stage Ⅰb (T2N0M0), 29 cases were stage Ⅱb (T2N1M0, T3N0M0) and 6 cases were stage Ⅲa T2N2M0); bronchial sleeve lobectomy in 43 cases, pulmonary artery and bronchial double sleeve lobectomy in 9 cases. Results: The operative mortality rate was 1.9% (1/52). Postoperative pulmonary atelectasis 3.8% (2/52), empyema 1.9% (1/52). The patients were followed up for 1 to 48 months. The 1-year survival rate was 80.21% and the 3-year survival rate was 38.23%. CONCLUSION: Sleeve resection with bronchial or pulmonary artery can improve the surgical resection rate of central lung cancer, protect the lung function to the maximum extent and ensure the postoperative quality of life.